genomic loss microrna leads overexpression histone methyltransferase ezh2 cancer 
enhancer zeste homolog ezh2 mammalian histone methyltransferase contributes epigenetic silencing target genes regulates survival metastasis cancer cells ezh2 overexpressed aggressive solid tumors mechanisms remain unclear show expression function ezh2 cancer cell lines inhibited microrna mir analysis human prostate tumors revealed mir expression decreases cancer progression paralleling increase ezh2 expression one two genomic loci encoding mir somatically lost % clinically localized prostate cancer cells % metastatic disease cells propose genomic loss mir cancer leads overexpression ezh2 concomitant dysregulation epigenetic pathways resulting cancer progression 
